Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

567
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
567
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

381
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
381
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

434
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
434
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

534
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
534
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.1K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and Control of a 1-DOF MRI Compatible Pneumatically Actuated Robot with Long Transmission Lines.

IEEE/ASME transactions on mechatronics : a joint publication of the IEEE Industrial Electronics Society and the ASME Dynamic Systems and Control Division·2011
Same author

Effect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake.

Journal of the Royal Society, Interface·2011
Same author

Acrolein hydrogenation on Pt(211) and Au(211) surfaces: a density functional theory study.

Physical chemistry chemical physics : PCCP·2011
Same author

Anhydrous proton-conducting membrane based on poly-2-vinylpyridinium dihydrogenphosphate for electrochemical applications.

The journal of physical chemistry. B·2011
Same author

Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors.

European journal of medicinal chemistry·2011
Same author

Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry.

Journal of pharmaceutical and biomedical analysis·2011

Related Experiment Video

Updated: Mar 15, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.2K

Management of type A dissection with malperfusion.

Bo Yang1, Himanshu J Patel1, David M Williams1

  • 1University of Michigan Medical Center, Ann Arbor, Michigan, USA.

Annals of Cardiothoracic Surgery
|August 27, 2016
PubMed
Summary

Optimal management for acute type A aortic dissection with malperfusion involves initial percutaneous reperfusion followed by open repair, showing superior long-term outcomes compared to immediate surgery.

Keywords:
Malperfusion syndromeacute type A aortic dissectionfenestration and stenting

More Related Videos

Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues
04:57

Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues

Published on: July 5, 2024

885
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Related Experiment Videos

Last Updated: Mar 15, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.2K
Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues
04:57

Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues

Published on: July 5, 2024

885
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Vascular Surgery

Background:

  • Malperfusion is a frequent and lethal complication of acute aortic dissection.
  • Optimal management strategies for acute type A aortic dissection with malperfusion remain unclear.

Purpose of the Study:

  • To reassess the management of acute type A aortic dissection (Type A-AAD) with malperfusion.
  • To compare outcomes of immediate open repair versus percutaneous reperfusion followed by open repair.

Main Methods:

  • Retrospective analysis of Type A-AAD patients with malperfusion at the University of Michigan.
  • Comparison of outcomes between direct open surgical repair and staged percutaneous reperfusion with subsequent open repair.

Main Results:

  • Patients treated with initial percutaneous reperfusion and delayed open repair had inferior short-term outcomes compared to uncomplicated Type A-AAD with immediate repair.
  • Long-term outcomes for patients undergoing initial percutaneous reperfusion and delayed open repair were superior to those treated with immediate open surgical intervention.

Conclusions:

  • A patient care protocol involving initial percutaneous reperfusion for Type A-AAD with malperfusion demonstrates superior long-term results.
  • The University of Michigan continues to utilize this protocol for treating Type A-AAD patients.